Politico – October 27, 2017
Scientists from The Feinstein Institute for Medical Research and Northwell Health’s Department of Internal Medicine, Cardiology and Cardio-thoracic Surgery examined the impact of left ventricular assist device, a popular pre-heart transplant therapy, on the kidney, according to an article in The Clinical Journal of the American Society of Nephrology. “More and more patients are surviving end-stage heart failure thanks to durable, implantable heart pumps, known as LVADs,” Dr. Gerin Rachel Stevens, an author of the study and director of cardiomyopathy at Northwell Health, said in a press release. Some of the interventions posed in the study include having a nephrologist on the medical team pre-implantation, enhanced training for dialysis nurses in the function of LAVD’s and identifying patients with chronic kidney disease prior to transplant. Read more about it here.